SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
AASTROM BIOSCIENCES INC
(NQSC:ASTM Last Sale: .31 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (ASTM : $.31)
$6 million Market Cap at September 12, 2013
Employs 45.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
24 Frank Lloyd Wright Drive Research Report Earnings Snapshot - Last 11/13/18
PO Box 376 Fact Sheet
Ann Arbor, MI 48106 Financial Statements
Phone: (734) 930-5555 Peer Comparison
Fax: (734) 665-0485 Annual Reports

George W. Dunbar, CEO/Pres., Gerald D. Brennan Jr., CFO
Developing cell production systems which are designed to replace human cells damaged by cancer chemotherapy. IPO at $7 February 3, 1997. Raised $21 MM, selling 3 MM shares, 22% of the outstanding. Lead Manager: Cowen & Co. Formed in 1989. Secondary sold 15.9 million shares at $1.60, raising $25.5 million, April 6, 2006.
Historical Charts    Technical Analysis
No Historical Data available for ASTM

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ASTM $.31 $ 0 $.3 $.3101 717,047 $.2651 $1.8 19,846
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $6,152

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
17-MAR-10 ASTM Split 1 for 8

A24
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex